Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher Disease
Condition(s):Lysosomal Storage Diseases; Gaucher Disease; SphingolipidosesLast Updated:May 28, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Lysosomal Storage Diseases; Gaucher Disease; SphingolipidosesLast Updated:May 28, 2021Completed
Condition(s):Lysosomal Storage Disorders; Gaucher Disease; Fabry Disease; Pompe Disease; Niemann-Pick DiseaseLast Updated:April 4, 2017Unknown status
Condition(s):Pompe Disease; Glycogen Storage Disease Type II; Lysosomal Storage DiseasesLast Updated:May 14, 2021Completed
Condition(s):Mucopolysaccharidosis I; Lysosomal Storage Diseases; Spinal Cord CompressionLast Updated:February 21, 2013Terminated
Condition(s):GalactosialidosisLast Updated:October 11, 2018Completed
Condition(s):Pompe Disease; Pompe Disease (Late-onset); Glycogen Storage Disease Type 2; LOPD; Lysosomal Storage Diseases; Acid Maltase DeficiencyLast Updated:March 24, 2023Completed
Condition(s):Fabry Disease; Fabry Disease, Cardiac Variant; Lysosomal Storage Diseases; HCM – Hypertrophic Cardiomyopathy; Anderson Fabry DiseaseLast Updated:July 8, 2021Unknown status
Condition(s):Inherited Metabolic Diseases; Lysosomal Storage Disorders; Peroxisomal Storage Diseases; Inborn Errors of Metabolism; MucopolysaccharidosisLast Updated:July 8, 2014Terminated
Condition(s):Genetic Disease; Inborn Errors of Metabolism; Glycogen Storage Disease; Lysosomal Storage Diseases; Storage DiseaseLast Updated:January 23, 2024Suspended
Condition(s):Hurler Syndrome; Inherited Metabolic Disorder; Lysosomal Storage Disorder; Metachromatic Leukodystrophy; Inborn Errors of MetabolismLast Updated:October 5, 2020No longer available
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.